122 related articles for article (PubMed ID: 24100865)
21. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
Kunnimalaiyaan M; Ndiaye M; Chen H
Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND
Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966
[TBL] [Abstract][Full Text] [Related]
24. [Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line].
Yu XX; Shi YA; Zhang LH; Wang YS; Wu S
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):323-7. PubMed ID: 18956651
[TBL] [Abstract][Full Text] [Related]
25. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition.
Han EK; Leverson JD; McGonigal T; Shah OJ; Woods KW; Hunter T; Giranda VL; Luo Y
Oncogene; 2007 Aug; 26(38):5655-61. PubMed ID: 17334390
[TBL] [Abstract][Full Text] [Related]
26. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.
Li B; Cheung PY; Wang X; Tsao SW; Ling MT; Wong YC; Cheung AL
Carcinogenesis; 2007 Nov; 28(11):2313-20. PubMed ID: 17638919
[TBL] [Abstract][Full Text] [Related]
27. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
28. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
29. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
Badinloo M; Esmaeili-Mahani S
Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
[TBL] [Abstract][Full Text] [Related]
31. alpha3beta1 integrin promotes cell survival via multiple interactions between 14-3-3 isoforms and proapoptotic proteins.
Oh JE; Jang DH; Kim H; Kang HK; Chung CP; Park WH; Min BM
Exp Cell Res; 2009 Nov; 315(18):3187-200. PubMed ID: 19683525
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro study on the role of 3,3'-diindolylmethane in treatment and prevention of nasopharyngeal carcinoma.
Chen C; Chen SM; Xu B; Chen Z; Wang F; Ren J; Xu Y; Wang Y; Xiao BK; Tao ZZ
Carcinogenesis; 2013 Aug; 34(8):1815-21. PubMed ID: 23568953
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
34. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
Cho SD; Lei P; Abdelrahim M; Yoon K; Liu S; Guo J; Papineni S; Chintharlapalli S; Safe S
Mol Carcinog; 2008 Apr; 47(4):252-63. PubMed ID: 17957723
[TBL] [Abstract][Full Text] [Related]
35. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression.
McDonald GT; Sullivan R; Paré GC; Graham CH
Exp Cell Res; 2010 Nov; 316(19):3197-206. PubMed ID: 20736003
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
Chen QZ; Li Y; Shao Y; Zeng YH; Ren WY; Liu RX; Zhou LY; Hu XL; Huang M; He F; Sun WJ; Wu K; He BC
Int J Oncol; 2017 Mar; 50(3):1011-1021. PubMed ID: 28197642
[TBL] [Abstract][Full Text] [Related]
38. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
Sarker KP; Lee KY
Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
[TBL] [Abstract][Full Text] [Related]
39. PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer.
Khan MW; Keshavarzian A; Gounaris E; Melson JE; Cheon EC; Blatner NR; Chen ZE; Tsai FN; Lee G; Ryu H; Barrett TA; Bentrem DJ; Beckhove P; Khazaie K
Clin Cancer Res; 2013 May; 19(9):2342-54. PubMed ID: 23487439
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
Yu C; Mao X; Li WX
Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
